VACCINE MANUFACTURING is a specialised process and, therefore, it is not possible to ramp up production overnight, said Adar Poonawalla, CEO of Serum Institute of India (SII), on Monday.
In a statement, the SII chief has said as of Monday, they have received total orders of over 26 crore doses, of which more than 15 crore have been supplied. “We have also got 100 per cent advance of Rs 1,732.50 crore by the government for the next tranche of 11 crore doses in the next few months. Another 11 crore doses will be supplied in the second channel for states and private hospitals in the next few months,” Poonawalla has said.
He has appealed for the need to understand that the population of India is massive, and that to produce enough doses is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations, he said.
Poonawalla said they have been working closely with the government since April last year, and have received all kinds of support, be it scientific, regulatory and financial.
He added that it was understandable that everyone wants the vaccine to be available in the quickest possible time, and assured that he is making all efforts to achieve that.
“That is our endeavour too and we are making every effort to achieve that. We shall work even harder and strengthen India’s fight against Covid-19,” Poonawalla has reiterated.
Earlier, in a tweet, he had stated the need to share correct information with the public. “Among multiple reports, it is important that correct information is shared with the public,” he had tweeted. In a statement, he later said his comments may have been misinterpreted.
In an interview to a London newspaper, he had spoken about receiving “aggressive” calls from some “powerful” people in the country demanding vaccine supply.